SUPPLY Resources

The SUPPLY Project consortium is an excellent example of solidarity: many stakeholders from different Member States working together to improve the lives of EU citizens. As the project outputs are those of the SUPPLY consortium, they cannot be considered to necessarily reflect the views of the European Blood Alliance or any individual organisation which forms part of the consortium. More details on the SUPPLY consortium can be found in the our partners section.

The SUPPLY project had many outputs including reports, tools, and position papers. Once the project has completed, all of these will be accessible and downloadable on this page. 

Deliverable Report
D1.1 Crisis Situations – The impact on the plasma-medicine-patient chain: Analysis and Recommendations (Scenario Evaluation Plan)
D2.1 Plasma Donor recruitment and retention – Current Practice (Analysis Report)
D2.2 Plasma Donor recruitment and retention strategies  – Efficiency evaluation (Recommendations Report and Transfer Plan)
D3.1 Setting up a Plasma Centre: Practical tools (Plasma Collection Recommendations and Support Tool)
D3.2 The plasma journey from collection to transport to fractionator – Recommendations for Improvement
D3.3 Opportunities to increase Plasma volumes: Recovered and via plasmapheresis: Analysis and Recommendations
D3.4 Real-world experience: Implementation of the recommendations to increase Plasma volumes
D3.6 Focus on quality: An assessment of plasma donor characteristics, Immunoglobulin, and Total Protein in donated plasma
D4.4 Member State steps on the European path to Strategic Independence for Plasma Medicines: A Position Paper
D4.6 Building Strategic Independence for Plasma Medicines: Policy Recommendations for the EU and EU Member States
D5.1 Protecting Plasma donor health: Current Practice (Analysis Report)
D5.2 Protecting Plasma donor health: a Support Tool for standardised Plasma Donor Vigilance data
D5.3 Protecting Plasma donor health: Recommendations
D6.1 Protecting Patients: ‘A comparative analysis on the current use of immunoglobulins in individual countries: A clinical program’
D6.2 Protecting Patients: ‘Final recommendations to achieve appropriate and prioritised use of immunoglobulins in Europe’
D7.3 ‘SUPPLY in a Nutshell’: Report for Laypersons